Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin and Subcutaneous Tissue Bacterial Infections”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)Study completedNCT01170221
What this trial is testing

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 667
Very early researchWithdrawnNCT04084665
What this trial is testing

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Who this might be right for
Hidradenitis Suppurativa
Rockefeller University
Large-scale testing (Phase 3)Active Not RecruitingNCT04179175
What this trial is testing

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 703
Large-scale testing (Phase 3)Looking for participantsNCT06768671
What this trial is testing

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 35
Not applicableActive Not RecruitingNCT06796231
What this trial is testing

Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis

Who this might be right for
Phaeohyphomycosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Large-scale testing (Phase 3)Active Not RecruitingNCT06411379
What this trial is testing

Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 418
Post-approval studies (Phase 4)Study completedNCT02572791
What this trial is testing

Staph Household Intervention for Eradication (SHINE)

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsStaphylococcus AureusMRSA - Methicillin Resistant Staphylococcus Aureus Infection
Washington University School of Medicine 835
Large-scale testing (Phase 3)Study completedNCT03713632
What this trial is testing

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 545
Large-scale testing (Phase 3)Active Not RecruitingNCT06411899
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 422
Testing effectiveness (Phase 2)Study completedNCT01283581
What this trial is testing

Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Melinta Therapeutics, Inc. 256
Large-scale testing (Phase 3)Study completedNCT01811732
What this trial is testing

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Melinta Therapeutics, Inc. 660
Testing effectiveness (Phase 2)Study completedNCT01519492
What this trial is testing

Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsWound InfectionCutaneous Abscess+2 more
Affinium Pharmaceuticals, Ltd 103
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Not applicableWithdrawnNCT01551719
What this trial is testing

Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation

Who this might be right for
Infection of Skin and/or Subcutaneous Tissue
Federico II University
Testing effectiveness (Phase 2)Study completedNCT03964493
What this trial is testing

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsGram-Positive Bacterial Infections
TenNor Therapeutics Limited 120
Large-scale testing (Phase 3)Enrolling By InvitationNCT07007637
What this trial is testing

Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
MoonLake Immunotherapeutics AG 835
Very early researchLooking for participantsNCT06326476
What this trial is testing

An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

Who this might be right for
Hidradenitis Suppurativa
University of Alabama at Birmingham 12
Not applicableStudy completedNCT02796716
What this trial is testing

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Who this might be right for
INFECTIONSSkin and Subcutaneous Tissue Bacterial InfectionsHealthcare-associated Infection+1 more
Denver Health and Hospital Authority 2,102
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Load More Results